Avidity Biosciences Inc.

NASDAQ: RNA · Real-Time Price · USD
46.46
0.39 (0.85%)
At close: Aug 15, 2025, 3:59 PM
46.25
-0.45%
After-hours: Aug 15, 2025, 06:04 PM EDT

Avidity Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
219.87M 185.08M 340.4M 320.45M
Short-Term Investments
1.28B 410.27M 270.33M 85.09M
Long-Term Investments
n/a n/a 251K 251K
Other Long-Term Assets
3.32M 596K 598K 599K
Receivables
28.22M 1.1M 2.36M 900K
Inventory
n/a n/a n/a -900K
Other Current Assets
n/a 7.52M 1.51M n/a
Total Current Assets
1.54B 611.31M 622.94M 411.14M
Property-Plant & Equipment
18.29M 16.65M 15.01M 15.59M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
21.61M 17.25M 15.86M 16.44M
Total Assets
1.56B 628.55M 638.8M 427.58M
Account Payables
8.46M 8.81M 4.64M 2.81M
Deferred Revenue
20.99M 28.36M 5.04M 4.86M
Short-Term Debt
n/a n/a n/a 1.77M
Other Current Liabilities
3.66M n/a n/a -1.77M
Total Current Liabilities
98.02M 80.68M 51.91M 29.66M
Long-Term Debt
n/a 6.21M 7.58M 9.96M
Other Long-Term Liabilities
n/a -6.21M -7.58M n/a
Total Long-Term Liabilities
40.92M 47.11M 8.82M 16.49M
Total Liabilities
138.94M 127.79M 60.73M 46.15M
Total Debt
6.8M 9.85M 10.69M 11.73M
Common Stock
12K 8K 7K 5K
Retained Earnings
-893.07M -570.76M -358.54M -184.55M
Comprehensive Income
2.9M 125K -2.7M -187K
Shareholders Equity
1.42B 500.76M 578.08M 381.43M
Total Investments
1.28B 410.27M 270.33M 85.09M